Business Wire

CHMP positive opinion to include RE-CIRCUIT® data for atrial fibrillation patients undergoing catheter ablation in Pradaxa® Summary of Product Characteristics

Jaa

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for an update to the European Summary of Product Characteristics (SmPC) of Pradaxa® (dabigatran etexilate) for the treatment of patients with atrial fibrillation (AF). The CHMP recommends to include recent RE-CIRCUIT® data, which showed lower rates of major bleeding for uninterrupted Pradaxa® 150 mg twice daily compared to warfarin in AF patients undergoing catheter ablation. The updated SmPC, if approved by the European Commission, will state that AF patients undergoing catheter ablation who take Pradaxa® 150 mg twice daily will not need to stop taking their Pradaxa® medication.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170918005473/en/

The results from RE-CIRCUIT ® showed that uninterrupted Pradaxa® was associated with a significant reduction in major bleeding event (MBE) rate compared with INR-adjusted warfarin in the setting of ablation. The data were originally presented earlier this year in a late-breaking session at the American College of Cardiology 66th Annual Scientific Session in Washington and simultaneously published in the New England Journal of Medicine. 1,2

In addition, an Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation3 was published by leading professional organisations including the European Heart Rhythm Association (EHRA) this week in the Heart Rhythm journal; the consensus from ablation experts around the world is that the data and worldwide experience regarding dabigatran now support a recommendation for performing AF ablation with uninterrupted Pradaxa® with the highest possible evidence level, a Class 1A recommendation.

“Optimal anticoagulation treatment during an AF ablation procedure is critically important as patients are at increased risk of complications for both bleeding and stroke. In the RE-CIRCUIT® trial, uninterrupted Pradaxa® was shown to be a much safer treatment choice with respect to major bleeding than warfarin,” commented Professor Jörg Kreuzer, Vice President Medicine, Therapeutic Area Cardiovascular, Boehringer Ingelheim. “The data recommended for inclusion in the Pradaxa® SmPC are a great piece of evidence on the benefits Pradaxa® can offer patients with atrial fibrillation and their treating physicians. We are pleased that both the CHMP as well as international professional bodies recognise the significance of these data in their recommendations to physicians.”

~Ends~

Please click on the link for ‘Notes to Editors’ and ‘References’: http://www.boehringer-ingelheim.com/CHMP-RE-CIRCUIT-label-update

For more information, please visitwww.boehringer-ingelheim.com

Further Media Channels

www.facebook.com/boehringeringelheim

www.twitter.com/Boehringer

Contact information

Boehringer Ingelheim GmbH
Corporate Communications
Media + PR
Friederike Middeke
Phone: +49 6132 – 77 141575
Fax: +49 6132 – 77 6601
E-mail: press@boehringer-ingelheim.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Easy Visual Launches App For Targeted Advertising Reach Through Smartphones26.9.2018 10:00Tiedote

Easy Visual has launched Banners App - a mobile application that shows targeted banners ads to users when they unlock their smartphones. Recent Boston Consulting Group research indicates that consumers spend 25% of their total offline and online media consumption time on mobile phones. However, advertisers spend only 12% of their budgets on mobile ads. Mobile advertising is unappreciated by some brands and it results in a loss of potential clients. Easy Visual has decided to change the situation. 69% of consumers from 18 to 39 years old use smartphones to look for products before buying them. Banners App offer brands and advertisers ads shown only to their target audiences, real views, statistics on the number of views and the conversion rate. Companies get potential customers, brand recognition and better ROI. It avoids brand reputational loss, because users voluntarily look at the advertising messages. Easy Visual is an innovative advertising network that provides advertisers and bra

SoftAtHome Invests in Quality of Experience for Fixed-Mobile Convergence by Acquiring V3D, Leader in Telecom Data Analytics26.9.2018 10:00Tiedote

SoftAtHome, the software company dedicated to the digital home, and V3D, a leading independent software vendor expert on Telecom data analytics for carrier network operators, announced today the signing of an acquisition agreement. With SoftAtHome acquiring V3D, the company will be able to deliver a full range of solutions around “analytics for Quality of Experience” for its fixed and mobile operator clients, by relying on the millions of data points collected by V3D. Thanks to both companies’ expertise, skills and solutions, Carrier Network Operators will benefit from a global value proposition on improving Customer Experience on their fixed and mobile networks. David VIRET-LANGE, Chief Executive Officer of SoftAtHome, commented: “In an increasingly digital world, consumers expect seamless connectivity with their mobile and tablets wherever they are. Quality of Experience will be naturally measured by the same solutions. The V3D solution portfolio and expertise on mobile and fixed net

NeoTract Announces Results from Five Real-World Studies Reaffirming Efficacy and Safety of UroLift® System Treatment for Enlarged Prostate26.9.2018 09:05Tiedote

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the World Congress of Endourology 2018 Annual Conference from five studies of the company’s novel UroLift® System for patients with Benign Prostatic Hyperplasia (BPH). “The real-world results from these studies of diverse patient populations on three continents reaffirm the sustained benefits of the UroLift System as an accepted standard of care treatment for patients with BPH,” said Dave Amerson, president of the NeoTract Interventional Urology business unit. “We are pleased that we continue to see results from real-world studies in line with our randomized pivotal study, demonstrating that the UroLift System is a safe and effective minimally invasive treatment that offers men long-term relief from the symptoms of BPH.” Five Studies Show Significant Relief and Improved Quality of Life with UroLift Sy

NeoTract Announces Results from Two Studies Demonstrating Transformative Benefits of the UroLift® System for BPH Care26.9.2018 09:05Tiedote

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced the presentation of new clinical data at the World Congress of Endourology 2018 Annual Conference from two U.K. studies of the company’s novel UroLift® System for patients with Benign Prostatic Hyperplasia (BPH). “This analysis of the UroLift System demonstrates its transformative impact on BPH care within a major health system,” said Dave Amerson, president of the NeoTract Interventional Urology business unit. “These real-world results continue to support the safety and efficacy of the UroLift System findings of our pivotal trial, and also suggest that the adoption of the UroLift System can save health systems millions in reduced organizational costs when compared to the traditional invasive surgical TURP procedure for patients with BPH.” U.K. Data Suggests UroLift System Greatly Reduces Costs Associated with TURP The Transforming BPH Surgi

Oliver Wyman Supports Inclusion Initiative in the Nordics26.9.2018 09:00Tiedote

Oliver Wyman announced today a new partnership with Ashoka, the world’s largest network for social entrepreneurs, to support a new inclusion fund called Hello Nordics. This fall, ten social entrepreneurs – eight from Denmark, Finland, Norway and Sweden and two internationals – will kick off a large-scale inclusion effort across the Nordic region. The entrepreneurs each bring their own unique approach to fostering integration and inclusion. Their common goal: to scale their solutions to better both social and financial inclusion of marginalized people in the Nordic region. The ten entrepreneurs have all been carefully selected based on their ability to address root causes in a systemic way, by involving policy makers, lawmakers, communities and target groups. The participants are Catalysts (NO), Sisters in Business (NO), Foreningen Nydansker (DK), GAME (DK), Startup Refugees (FI), Icehearts (FI), Mitt Liv (SE), Idrott Utan Gränser (SE), Welcoming International (USA/Germany) and ACAF/Win

"Panasonic Prime Smash!" Has Been Given a Complete Makeover - An iPhone, iPad Game That Awakens Children's Interest in Mathematics26.9.2018 06:05Tiedote

On August 28, 2018, Panasonic Corporation gave the iPad app, "Panasonic Prime Smash!" a complete makeover. The new release includes the iOS 11 compatible iPhone app as well. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180925006294/en/ The screen of "Panasonic Prime Smash!": In the game, balls with numbers are blown. If it is a prime number, capture it by tapping the ball. (Graphic: Business Wire) [Video] Smartphone game application "Panasonic Prime Smash!" https://channel.panasonic.com/contents/24401/ "Panasonic Prime Smash!" overview "Panasonic Prime Smash!" is a game app that teaches children about the atom of numbers, or prime numbers in a fun, enjoyable way. Balls bearing numbers will appear on the screen one after another. If the number is a prime number, you touch that number. If the number is not a prime number, you "Smash" it, transform it into a prime number, and then touch it. That number will be added to your t

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme